4/10/2013

21st Century Biochemicals agreed to sell its line of Epi-Plus antibodies, which are used in epigenetic studies, to Rockland Immunochemicals. The price was not disclosed. The deal will bolster Rockland's life science tools portfolio. The Epi-Plus brand is co-owned by Novus Biologicals.

Related Summaries